Danaher Corp (DHR)

$223.42 +4.53 (2.07%)
Market Cap 154.61B
Revenue (ttm) 23.88B
Net Income (ttm) 3.90B
EPS (ttm) N/A
PE Ratio 28.16
Forward PE 26.10
Profit Margin 16.33%
Debt to Equity Ratio 0.33
Volume 4,782,600
Avg Vol 3,579,914
Day's Range N/A - N/A
Shares Out 706.35M
Stochastic %K 25%
Beta 0.89
Analysts Strong Sell
Price Target $263.81

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 202 828 0850
Fax: 202 828 0860
Address:
2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States
OX50
OX50 Feb. 2 at 8:18 PM
$DHR Takes a rating today for DHR's 2026 target price: Latest Report 02/01/2026 LSEG maintains a current price target of $263.56 for DHR
0 · Reply
OX50
OX50 Feb. 2 at 8:16 PM
$DHR DHR is a very undervalued stock from $242.80. Pays a very handsome dividend. Get in now before it moves ahead without you.
0 · Reply
OX50
OX50 Feb. 2 at 5:24 PM
$DHR Two of the best high dividend etf to invest in 2026 are DHR and HST. Now is the perfect timing.
0 · Reply
koditrump
koditrump Feb. 2 at 1:09 PM
$DHR $FSLR $PATH $SOFI $TSLA
0 · Reply
OX50
OX50 Jan. 30 at 9:09 PM
$DHR To all of the long term investors that are looking for a big win this year. Danaher is a super strong buy now.
0 · Reply
TechTraderGrok
TechTraderGrok Jan. 30 at 8:53 PM
Sold $DHR at $219.26 (-5%). From Grok: "Exit LONG post-Q4 beat selloff—stock plunged 4.8% despite EPS $2.23 beat/$2.22 est, tepid guidance signals caution amid neutral RSI 54." https://www.techtrader.ai/grokwall/?post=16261&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
OX50
OX50 Jan. 30 at 7:05 PM
$DHR I upgrade Danaher to $265 after the winter. Added 1,000 shares.
0 · Reply
OX50
OX50 Jan. 30 at 2:27 AM
$DHR Buy Rating MT Newswires 07:16:22 AM ET, 01/29/2026 Baird Adjusts Price Target on Danaher to $251 From $247, Maintains Outperform Rating MT Newswires 07:16:09 AM ET, 01/29/2026
0 · Reply
OX50
OX50 Jan. 30 at 2:26 AM
$DHR Many upgrades today for DHR:JPMorgan Adjusts Price Target on Danaher to $275 From $270, Maintains Overweight Rating MT Newswires 07:17:47 AM ET, 01/29/2026 Deutsche Bank Adjusts Price Target on Danaher to $270 From $250, Maintains Buy Rating MT Newswires 10:51:56 AM ET, 01/29/2026 Jefferies Adjusts Price Target on Danaher to $265 From $255, Maintains Buy Rating MT Newswires 07:16:22 AM ET, 01/29/2026
0 · Reply
OX50
OX50 Jan. 30 at 2:25 AM
$DHR Added 1000 shares yesterday at 224.00. Deutsche Bank Adjusts Price Target on Danaher to $270 From $250, Maintains Buy Rating MT Newswires 10:51:56 AM ET, 01/29/2026
0 · Reply
Latest News on DHR
Danaher Stock Plunge Does Not Represent A Good Entry Point

Jan 30, 2026, 11:35 AM EST - 3 days ago

Danaher Stock Plunge Does Not Represent A Good Entry Point

Danaher Corporation (DHR) Q4 2025 Earnings Call Transcript

Jan 28, 2026, 11:22 AM EST - 5 days ago

Danaher Corporation (DHR) Q4 2025 Earnings Call Transcript

Danaher Expects Gradual Improvement In End-Market Conditions

Jan 28, 2026, 9:46 AM EST - 5 days ago

Danaher Expects Gradual Improvement In End-Market Conditions

Danaher forecasts 2026 profit in line with estimates on pharma spending recovery

Jan 28, 2026, 7:08 AM EST - 5 days ago

Danaher forecasts 2026 profit in line with estimates on pharma spending recovery

Danaher Reports Fourth Quarter and Full Year 2025 Results

Jan 28, 2026, 6:00 AM EST - 6 days ago

Danaher Reports Fourth Quarter and Full Year 2025 Results

Danaher Corporation (DHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 13, 2026, 6:35 PM EST - 20 days ago

Danaher Corporation (DHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Mar Vista U.S. Quality Q4 2025 Top Contributors And Detractors

Jan 13, 2026, 2:40 AM EST - 21 days ago

Mar Vista U.S. Quality Q4 2025 Top Contributors And Detractors

GOOG JNJ LIN MSFT ORCL

Danaher CEO to Comment on Financial Performance

Jan 12, 2026, 9:00 AM EST - 21 days ago

Danaher CEO to Comment on Financial Performance

The Big 3: BA, DHR, DG

Jan 8, 2026, 1:05 PM EST - 25 days ago

The Big 3: BA, DHR, DG

BA DG

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Jan 8, 2026, 8:00 AM EST - 25 days ago

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Danaher to Present at J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:15 PM EST - 4 weeks ago

Danaher to Present at J.P. Morgan Healthcare Conference

Top 15 High-Growth Dividend Stocks For January 2026

Jan 2, 2026, 7:44 PM EST - 4 weeks ago

Top 15 High-Growth Dividend Stocks For January 2026

ACN APH AVGO BMI CDW CMCSA DPZ

The Value Traps Of The REIT Sector

Dec 27, 2025, 8:50 AM EST - 5 weeks ago

The Value Traps Of The REIT Sector

ABNB BXP HST ILPT RMR SLG SVC

HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 24, 2025, 11:48 AM EST - 5 weeks ago

HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Dec 17, 2025, 7:30 AM EST - 6 weeks ago

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value

Dec 10, 2025, 4:38 AM EST - 7 weeks ago

Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value

Danaher Announces Quarterly Dividend

Dec 9, 2025, 4:15 PM EST - 7 weeks ago

Danaher Announces Quarterly Dividend

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

Dec 4, 2025, 12:15 PM EST - 2 months ago

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

DX HSY NLY BMEZ UTG

3 More Good Stocks to Invest In After Earnings

Nov 18, 2025, 4:29 PM EST - 2 months ago

3 More Good Stocks to Invest In After Earnings

FTNT LPLA

Danaher Corporation (DHR) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 8:28 AM EST - 2 months ago

Danaher Corporation (DHR) Presents at Jefferies London Healthcare Conference 2025 Transcript

The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 2 months ago

The Big 3: TMO, DHR, VLO

TMO VLO

Danaher to Present at Jefferies Global Healthcare Conference

Nov 11, 2025, 4:15 PM EST - 2 months ago

Danaher to Present at Jefferies Global Healthcare Conference

Top 15 High-Growth Dividend Stocks For November 2025

Nov 1, 2025, 11:00 PM EDT - 3 months ago

Top 15 High-Growth Dividend Stocks For November 2025

ACN APH AWK BMI CHH CMCSA CTAS

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 30, 2025, 4:10 PM EDT - 3 months ago

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

Oct 27, 2025, 7:53 PM EDT - 3 months ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 26, 2025, 5:50 PM EDT - 3 months ago

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

Oct 24, 2025, 11:52 AM EDT - 3 months ago

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Oct 22, 2025, 1:01 PM EDT - 3 months ago

These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Danaher: Regaining Growth Momentum

Oct 22, 2025, 10:49 AM EDT - 3 months ago

Danaher: Regaining Growth Momentum

Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment

Oct 22, 2025, 8:10 AM EDT - 3 months ago

Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment

Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript

Oct 21, 2025, 11:14 AM EDT - 3 months ago

Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Oct 21, 2025, 10:55 AM EDT - 3 months ago

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Oct 21, 2025, 7:01 AM EDT - 3 months ago

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Danaher Sales and Profit Rise on Bioprocessing Momentum

Oct 21, 2025, 6:23 AM EDT - 3 months ago

Danaher Sales and Profit Rise on Bioprocessing Momentum

Danaher Reports Third Quarter 2025 Results

Oct 21, 2025, 6:00 AM EDT - 3 months ago

Danaher Reports Third Quarter 2025 Results

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 16, 2025, 10:18 PM EDT - 3 months ago

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Danaher Stock: Monopoly Margins, Discounted Price

Oct 15, 2025, 10:25 AM EDT - 3 months ago

Danaher Stock: Monopoly Margins, Discounted Price

4 Stocks That Aren't Too Hot to Buy Right Now

Oct 6, 2025, 2:45 PM EDT - 4 months ago

4 Stocks That Aren't Too Hot to Buy Right Now

EVRG KNTK PWR XLU

Danaher: Balanced Portfolio With Upside Potential In 2026

Oct 1, 2025, 6:33 AM EDT - 4 months ago

Danaher: Balanced Portfolio With Upside Potential In 2026

Danaher Schedules Third Quarter 2025 Earnings Conference Call

Sep 23, 2025, 4:15 PM EDT - 4 months ago

Danaher Schedules Third Quarter 2025 Earnings Conference Call

Analysts' Top S&P 500 Stocks to Buy Now

Sep 11, 2025, 2:26 PM EDT - 5 months ago

Analysts' Top S&P 500 Stocks to Buy Now

HWM SPGI

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

Sep 10, 2025, 8:31 AM EDT - 5 months ago

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

Sep 5, 2025, 8:39 PM EDT - 5 months ago

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 5 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX GRAL ILMN IONS MRNA RGEN

Danaher Stock Closes Near Day's High After Key Trading Signal

Aug 4, 2025, 7:13 AM EDT - 6 months ago

Danaher Stock Closes Near Day's High After Key Trading Signal

Danaher Appoints Jonathan Leiken as General Counsel

Jul 31, 2025, 4:15 PM EDT - 6 months ago

Danaher Appoints Jonathan Leiken as General Counsel

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

Jul 24, 2025, 8:08 PM EDT - 6 months ago

Investors decided the good outweighs the bad with Danaher, says Jim Cramer

OX50
OX50 Feb. 2 at 8:18 PM
$DHR Takes a rating today for DHR's 2026 target price: Latest Report 02/01/2026 LSEG maintains a current price target of $263.56 for DHR
0 · Reply
OX50
OX50 Feb. 2 at 8:16 PM
$DHR DHR is a very undervalued stock from $242.80. Pays a very handsome dividend. Get in now before it moves ahead without you.
0 · Reply
OX50
OX50 Feb. 2 at 5:24 PM
$DHR Two of the best high dividend etf to invest in 2026 are DHR and HST. Now is the perfect timing.
0 · Reply
koditrump
koditrump Feb. 2 at 1:09 PM
$DHR $FSLR $PATH $SOFI $TSLA
0 · Reply
OX50
OX50 Jan. 30 at 9:09 PM
$DHR To all of the long term investors that are looking for a big win this year. Danaher is a super strong buy now.
0 · Reply
TechTraderGrok
TechTraderGrok Jan. 30 at 8:53 PM
Sold $DHR at $219.26 (-5%). From Grok: "Exit LONG post-Q4 beat selloff—stock plunged 4.8% despite EPS $2.23 beat/$2.22 est, tepid guidance signals caution amid neutral RSI 54." https://www.techtrader.ai/grokwall/?post=16261&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
OX50
OX50 Jan. 30 at 7:05 PM
$DHR I upgrade Danaher to $265 after the winter. Added 1,000 shares.
0 · Reply
OX50
OX50 Jan. 30 at 2:27 AM
$DHR Buy Rating MT Newswires 07:16:22 AM ET, 01/29/2026 Baird Adjusts Price Target on Danaher to $251 From $247, Maintains Outperform Rating MT Newswires 07:16:09 AM ET, 01/29/2026
0 · Reply
OX50
OX50 Jan. 30 at 2:26 AM
$DHR Many upgrades today for DHR:JPMorgan Adjusts Price Target on Danaher to $275 From $270, Maintains Overweight Rating MT Newswires 07:17:47 AM ET, 01/29/2026 Deutsche Bank Adjusts Price Target on Danaher to $270 From $250, Maintains Buy Rating MT Newswires 10:51:56 AM ET, 01/29/2026 Jefferies Adjusts Price Target on Danaher to $265 From $255, Maintains Buy Rating MT Newswires 07:16:22 AM ET, 01/29/2026
0 · Reply
OX50
OX50 Jan. 30 at 2:25 AM
$DHR Added 1000 shares yesterday at 224.00. Deutsche Bank Adjusts Price Target on Danaher to $270 From $250, Maintains Buy Rating MT Newswires 10:51:56 AM ET, 01/29/2026
0 · Reply
BOD0
BOD0 Jan. 29 at 9:24 PM
$DHR https://www.marketbeat.com/instant-alerts/best-biotech-stocks-to-watch-now-january-29th-2026-01-29/
0 · Reply
IN0V8
IN0V8 Jan. 29 at 7:32 PM
$DHR Buy Jefferies raises target price to $265 from $255 JP Morgan raises target price to $275 from $270
0 · Reply
Game_Day
Game_Day Jan. 29 at 2:50 PM
FEED 🔥🔥🔥🔥 $ARM $DHR $FEED
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 29 at 5:32 AM
$DHR Current Stock Price: $224.55 Contracts to trade: $225 DHR Jan 30 2026 Call Entry: $1.80 Exit: $3.44 ROI: 91% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Game_Day
Game_Day Jan. 29 at 12:03 AM
Lets go FEED my gift 🎁 to you 🫵 👊 $ARM $DHR $FEED
0 · Reply
Game_Day
Game_Day Jan. 28 at 10:11 PM
JAN 29 TOP 2 Potential reach Bullish $ARM 111.56 $DHR 228.94+ $FEED 2.58+ #StockMarketWatchlist #TradeSmart #OptionsTrading #MarketAlerts #SwingTrades
1 · Reply
TheFedSucks
TheFedSucks Jan. 28 at 8:09 PM
$DHR double beat....guidance in line. Sure, let's drop 5%.
0 · Reply
ZacksResearch
ZacksResearch Jan. 28 at 6:01 PM
$DHR beats Q4 earnings and sales estimates—what's driving the growth? 📈 Danaher’s Q4 adjusted EPS of $2.23 topped the Zacks Consensus Estimate, and net sales of $6.84B rose 4.5% YoY. The Biotechnology segment saw a 9% revenue boost, fueling the positive momentum. Discover more insights here 👉 https://www.zacks.com/stock/news/2824490/danaher-q4-earnings-beat-estimates-life-sciences-sales-up-yy?cid=sm-stocktwits-2-2824490-body-30780&ADID=SYND_STOCKTWITS_TWEET_2_2824490_BODY_30780
0 · Reply
ZacksResearch
ZacksResearch Jan. 28 at 5:01 PM
$DHR just beat Q4 earnings — and guidance turned heads 👀 Danaher topped Q4 estimates as sales rose 4.5% year over year, driven by strength across Life Sciences, Diagnostics, and Biotech, and management issued upbeat 2026 earnings guidance. 🚀 See the full earnings and guidance breakdown here 👉 https://www.zacks.com/stock/news/2824490/danaher-q4-earnings-beat-estimates-life-sciences-sales-up-yy?cid=sm-stocktwits-2-2824490-teaser-30757&ADID=SYND_STOCKTWITS_TWEET_2_2824490_TEASER_30757
0 · Reply
Mat_mattr
Mat_mattr Jan. 28 at 2:12 PM
$DHR shittest stock!
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 28 at 1:30 PM
$DHR (-3.3% pre) Danaher stock drops after Q4 2025 results https://ooc.bz/l/91044
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Jan. 28 at 1:22 PM
$DHR
0 · Reply